Nasus Pharma Ltd

Nasus Pharma Ltd (NSRX) has logged zero cyber incidents and zero red-flag 8-K filings over the past 90 days, indicating surface-level stability in our near-term monitoring window. However, absence of recent events does not eliminate structural risk; a 90-day snapshot misses dilution cycles, financing pressure, and earlier-period volatility that shape shareholder value. The full $49 Report extends analysis to 12 months of filings, calculates dilution risk scores, maps financing history and capital structure, and surfaces AI-detected risk signals that short windows cannot capture. This deeper context transforms passive observation into actionable risk assessment.